Scott Alan Campbell
Associate Professor of Clinical Psychiatry
Pharmacy and Clinical Therapeutics Committee Member, Pennsylvania Hospital
Physician Leader/ Member, Unit Based Clinical Leadership (UBCL) Committee for the Department of Psychiatry at Pennsylvania Hospital.
Director of Consult-Liaison Psychiatry Service, Pennsylvania Hospital, UPHS
Director of Inpatient Psychiatry Unit, Pennsylvania Hospital, UPHS
Site Coordinator & Member for Quality Improvement Residency Curriculum Development Committee, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania
Clinical Competency Committee Member, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania
Course Director for PSY300 Inpatient Psychiatry, Pennsylvania Hospital, Perelman School of Medicine, University of Pennsylvania, University of Pennsylvania
Executive Committee Member, Pennsylvania Hospital
Director, Psychiatry Residency Training Program, University of Pennsylvania School of Medicine
Vice Chair of Education, Department of Psychiatry, University of Pennsylvania School of Medicine
Department: Psychiatry
Contact information
3535 Market St, Ste 200
Philadelphia, PA 19104
Philadelphia, PA 19104
Education:
BS (Biology)
Dickinson College, 2002.
MD
University of Pennsylvania School of Medicine, 2006.
Residency (Psychiatry Residency)
Hospital of the University of Pennsylvania, 2010.
BS (Biology)
Dickinson College, 2002.
MD
University of Pennsylvania School of Medicine, 2006.
Residency (Psychiatry Residency)
Hospital of the University of Pennsylvania, 2010.
Post-Graduate Training
Internship in Psychiatry, Hospital of the University of Pennsylvania, 2006-2007.
Resident in Psychiatry, Hospital of the University of Pennsylvania, 2007-2010.
Chief Resident of Inpatient Psychiatry Services, Hospital of the University of Pennsylvania, 2009-2010.
Good Psychiatric Management Training for Borderline Personality Disorder, John Gunderson, MD Lois W. Choi-Kain, M.D. M.Ed. McLean Borderline Personality Disorders Training Institute (BPDTI), 2014-2014.
Permanent linkInternship in Psychiatry, Hospital of the University of Pennsylvania, 2006-2007.
Resident in Psychiatry, Hospital of the University of Pennsylvania, 2007-2010.
Chief Resident of Inpatient Psychiatry Services, Hospital of the University of Pennsylvania, 2009-2010.
Good Psychiatric Management Training for Borderline Personality Disorder, John Gunderson, MD Lois W. Choi-Kain, M.D. M.Ed. McLean Borderline Personality Disorders Training Institute (BPDTI), 2014-2014.
Selected Publications
Le TM, Campbell S, Andraos A, Ahlmark P, Hoang H, Isserman S, Goldzweig CL, Mays AM, Bradley K, Keller MS.: Implementation of an intervention aimed at deprescribing benzodiazepines in a large US healthcare system using patient education materials: a pre/post-observational study with a control group. BMJ Open 14: e080109, Apr 2024.Tania Gregorian, Kristin Bradley, Scott Campbell, Rachel Mashburn, Richard Beuttler, Michelle S Keller : Design, implementation, and evaluation of a pharmacist-led outpatient benzodiazepine-tapering clinic. Journal of the American Pharmacists Association. Elsevier, 63: 409-415, January 2023.
Lau, R., Andraos, A., Mak Slevin, J., Wasif, M., Campbell, S. : Evaluation of the Pharmacist Led Benzodiazepine Taper Program at Cedars-Sinai Medical Network. ASHP (American Society of Health-System Pharmacists) Midyear 2022 Clinical Meeting & Exhibition December 2022.
Reist C, Petiwala I, Latimer J, Raffaelli SB, Chiang M, Eisenberg D, Campbell S.: Collaborative mental health care: A narrative review. Medicine (Baltimore) 101: e32554, Dec 2022.
Keller, M. S., Kiefer, E., Campbell, S., Bradley, K., Mashburn, R., Bawa, M., & Goldzweig, C. : Sustained Increase of Sedative-Hypnotic Prescribing During the COVID-19 Pandemic in a Large Urban Health System: an Observational Study. Journal of General Internal Medicine. Springer International Publishing, 36(11): 3618-3620, May 2021.
Zickmund Susan L, Campbell Scott A, Tirado Carlos F, Zook Carolyn L, Weinrieb Robert M: Perceived Barriers to Hepatitis C Therapy for Patients Receiving Opioid Agonist Treatment. Journal of addiction medicine 6(3): 233-239, Sep 2012.
S Zickmund, C Tirado, S Campbell, R Weinrieb: Provider communication cited as barrier to antiviral therapy for hepatitis C-infected methadone using patients. Abstracts from the 31st Annual Meeting of the Society of General Internal Medicine Society of General Internal Medicine 31st Annual Meeting Pittsburgh, Pennsylvania April 9-12, 2008. Springer, 23: 383-383, March 2008.
Campbell, S., Weinrieb, R.M., Tirado, C., Zickmund, S., Arndt, R. : A Randomized, Placebo Controlled Study of Citalopram for Interferon Associated Psychiatric Side Effects in Methadone Maintained Hepatitis C Infected Veterans. APM (Academy of Psychosomatic Medicine) Annual Meeting, November 2008 2008.
Zwemer, C.F., Campbell, S., Coleman, E., Ellerman, J., Levit, R., Lucin, K., & Ritchie, C. : Decreased VO2 in response to acute inspired hypoxia and hypercapnic hypoxia in rabbits (O. cuniculus). Experimental Biology Annual Meeting, April 2002. 2002.
Cordes, J., Campbell, S., & Wright, J. : Raccoon Roundworm (Baylisascaris procyonis) as a Factor in the Decline of the Allegheny Woodrat (Neotoma magister). 77th Annual Meeting of the Pennsylvania Academy of Science, 2001. 2001.